INS and Hyperglycemia: This prospective cohort study aimed to investigate whether hyperglycemia persists in patients who survive severe COVID-19 over a follow-up period of 6 months and to explore possible causes of hyperglycemia, including insulin sensitivity/secretion, energy expenditure, substrate preference, and metabolic flexibility.